Management of Antitubercular Drug Induced Hepatoxicity

Written By: user Dr. Lalit Shimpi
Published On: 16 Apr, 2021 5:48 PM | Updated On: 23 Nov, 2024 2:47 AM

Management of Antitubercular Drug Induced Hepatoxicity

Is it necessary to screen patients for existing liver diseases or know their complete history before starting them on antitubercular drugs? Watch this video where Dr. Lalit Shimpi talks about the approach to managing antitubercular medications induced liver damage.

user
Dr. Lalit Shimpi

Dr Lalit Shimpi is an ingenious Physician from Pune, specialising in Pancreatico Biliary diseases, Therapeutic Endoscopy, Endosonography, Liver diseases and Gasteroenterology. His areas of interest include Therapeutic Pancreatic, Biliary Endoscopy and Palliative care in GI cancers. He has performed more than 1600 ERCP's in the last 8 years of practice.

 More FAQs by Dr. Lalit Shimpi
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks